Pricing Log in Create free account

Telesis Bio Inc. (TBIO) vs VolitionRX Limited (VNRX)

Telesis Bio Inc. and VolitionRX Limited are both Medical Devices companies. Telesis Bio Inc. and VolitionRX Limited are of similar size ($5.3M and $5.3M). VolitionRX Limited grew revenue faster over the last twelve months: 86.3% against −38.1%. Telesis Bio Inc. has the higher net margin (−287.9% vs −1,043.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Telesis Bio Inc. leads on 8 and VolitionRX Limited on 8.

Valuation

Metric TBIO VNRX Medical Devices median
P/E n/m n/m 23.22
P/S 0.00 0.67 2.34
P/B n/m n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 0.10 4.01 2.24
Earnings yield (70,502.50%) (2,122.22%) (10.09%)
Free cash flow yield (33,623.80%) (1,206.46%) (8.47%)

Profitability

Metric TBIO VNRX Medical Devices median
Gross margin 45.62% 100.00% 56.01%
Operating margin (265.73%) (790.20%) (15.03%)
Net margin (287.90%) (1,043.08%) (20.40%)
Free cash flow margin (143.25%) (796.73%) (7.24%)
Return on equity 1,013.88% 76.95% (15.32%)
Return on assets (73.87%) (301.54%) (19.72%)
Return on invested capital 0.00% 0.00% (10.33%)

Growth

Metric TBIO VNRX Medical Devices median
Revenue growth (TTM) (38.09%) 86.32% 8.80%
EPS growth (last fiscal year) 0.61% 29.03% 29.03%
Revenue growth, 5-year CAGR 41.76% 164.28% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TBIO VNRX Medical Devices median
Debt to equity (0.23) (0.33) 0.07
Current ratio 1.23 0.30 2.50
Net debt to EBITDA 0.46 (0.52) 0.49

Dividend

Metric TBIO VNRX Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric TBIO VNRX Medical Devices median
Market cap 5.31m 5.25m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack